Trajectories of brain development: Point of vulnerability or window of opportunity?

Neuroscience and Biobehavioral Reviews

Volumn 27, Issue 1-2, 2003, Pages 3-18

  Andersen, Susan L ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

Adolescence; Development; Insult; Sex; Vulnerability

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 4 AMINOBUTYRIC ACID RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING); BRAIN DERIVED NEUROTROPHIC FACTOR; COCAINE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; METHYLPHENIDATE; N METHYL BETA CARBOLINE 3 CARBOXAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; NEUROTROPHIN; SEROTONIN 7 RECEPTOR; SULPIRIDE; TYROSINE 3 MONOOXYGENASE;

ADOLESCENCE; ADULTHOOD; ATTENTION DEFICIT DISORDER; BEHAVIOR; BRAIN DEVELOPMENT; CELL DIFFERENTIATION; CELL MIGRATION; CHILDHOOD; CONFERENCE PAPER; DENDRITE; DEPOLARIZATION; DEPRESSION; DOPAMINE RELEASE; DOSE RESPONSE; DRUG EFFECT; DRUG SENSITIVITY; GILLES DE LA TOURETTE SYNDROME; HEREDITY; HUMAN; IMMUNOREACTIVITY; INNERVATION; MENTAL DISEASE; MYELINATION; NERVE CELL PLASTICITY; NERVE FIBER; NONHUMAN; POSTNATAL DEVELOPMENT; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; SCHIZOPHRENIA; SEX DIFFERENCE; STEM CELL; STRESS; SUBSTANCE ABUSE; SYNAPSE;

EID: 0038407848     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(03)00005-8     Document Type: Conference Paper

References (233)

1. Allen L.S., Gorski R.A. Sexual orientation and the size of the anterior commissure in the human brain. Proc Natl Acad Sci USA. 89:(15):1992;7199-7202.
2. Allen N.B., Lewinsohn P.M., Seeley J.R. Prenatal and perinatal influences on risk for psychopathology in childhood and adolescence. Dev Psychopathol. 10:(3):1998;513-529.
3. Almasy L., Blangero J. Endophenotypes as quantitative risk factors for psychiatric disease: rationale and study design. Am J Med Genet. 105:(1):2001;42-44.
4. Andersen S. Changes in the second messenger cyclic AMP during development may underlie motoric symptoms in attention deficit/hyperactivity disorder (ADHD). Behav Brain Res. 130:2002;197-201.
5. Andersen S., Dumont N., Teicher M. Differences in behavior and monoamine laterality following neonatal clomipramine treatment. Dev Psychobiol. 41:2002;50-57.
6. Andersen S., Thompson A., Krenzel E., Teicher M. Pubertal changes in gonadal hormones do not underlie adolescent dopamine receptor overproduction. Psychoneuroendocrinology. 27:(6):2002;683-691.
7. Andersen S.L., Arvanitogiannis A., Pliakas A.M., LeBlanc C., Carlezon W.A. Jr. Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci. 5:(1):2002;13-14.
8. Andersen S.L., Dumont N.L., Teicher M.H. Developmental differences in dopamine synthesis inhibition by 7-OHDPAT. Naunyn Schmiedeberg's Arch Pharmacol. 356:1997;173-181.
9. Andersen S.L., Gazzara R.A. The ontogeny of apomorphine-induced alterations in dopamine release: I. Effects on spontaneous release. J Neurochem. 61:1993;2247-2255.
10. Andersen S.L., Gazzara R.A. The development of D2 autoreceptor-mediated modulation of K(+)-evoked dopamine release in the neostriatum. Brain Res Dev Brain Res. 78:(1):1994;123-130.
11. Andersen S.L., Gazzara R.A. Effects of (-) sulpiride on dopamine release in striatum of developing rats: degree of depolarization influences responsiveness. J Neurochem. 67:1996;1931-1937.
12. Andersen S.L., LeBlanc C.J., Lyss P.J. Maturational increases in c-fos expression in the ascending dopamine systems. Synapse. 41:(4):2001;345-350.
13. Andersen S.L., Rutstein M., Benzo J.M., Hostetter J.C., Teicher M.H. Sex differences in dopamine receptor overproduction and elimination. Neuroreport. 8:(6):1997;1495-1498.
14. Andersen S.L., Teicher M.H. Sex differences in dopamine receptors and their relevance to ADHD. Neurosci Biobehav Rev. 24:(1):2000;137-141.
15. Andersen S.L., Thompson A.T., Rutstein M., Hostetter J.C., Teicher M.H. Dopamine receptor pruning in prefrontal cortex during the periadolescent period in rats. Synapse. 37:(2):2000;167-169.
16. Anderson S.A., Classey J.D., Conde F., Lund J.S., Lewis D.A. Synchronous development of pyramidal neuron dendritic spines and parvalbumine-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex. Neuroscience. 67:1995;7-22.
17. Association A.P. Diagnostic and statistical manual for mental disorders. 4th ed: 1994; American Psychiatric Press, Washington, DC. DSM-IV.
18. Avishai-Eliner S., Brunson K.L., Sandman C.A., Baram T.Z. Stressed-out, or in (utero)? Trends Neurosci. 25:(10):2002;518-524.
19. Baird A.A., Gruber S.A., Fein D.A., Maas L.C., Steingard R.J., Renshaw P.F., Cohen B.M., Yurgelun-Todd D.A. Functional magnetic resonance imaging of facial affect recognition in children and adolescents. J Am Acad Child Adolesc Psychiatry. 38:(2):1999;195-199.
20. Barks J.D., Silverstein F.S., Sims K., Greenamyre J.T., Johnston M.V. Glutamate recognition sites in human fetal brain. Neurosci Lett. 84:1988;131-136.
21. Beaudet A.L., Jiang Y.H. A rheostat model for a rapid and reversible form of imprinting-dependent evolution. Am J Hum Genet. 70:(6):2002;1389-1397.
22. Becker J.B., Beer M.E. The influence of estrogen on nigrostriatal dopamine activity: behavioral and neurochemical evidence for both pre- and postsynaptic components. Behav Brain Res. 19:(1):1986;27-33.
23. Becker J.B., Robinson T.E., Lorenz K.A. Sex differences and estrous cycle variations in amphetamine elicited rotational behavior. Eur J Pharmacol. 80:1982;65-72.
24. Bedard P.J., Malouin F., Dipaolo T., Labrie F. Estradiol TRH and striatal dopaminergic mechanisms. Prog Neuropsychopharmacol Biol Psychiatry. 6:(4-6):1982;555-561.
25. Benes F.M. The role of stress and dopamine-GABA interactions in the vulnerability for schizophrenia. J Psychiatr Res. 31:(2):1997;257-275.
26. Benes F.M. Emerging principles of altered neural circuitry in schizophrenia. Brain Res Brain Res Rev. 31:(2-3):2000;251-269.
27. Benes F.M., Turtle M., Khan Y., Farol P. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch Gen Psychiatry. 51:(6):1994;477-484.
28. Biederman J., Wilens T., Mick E., Spencer T., Faraone S.V. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics. 104:(2):1999;e20.
29. Bird H.R., Canino G., Rubio-Stipec M., et al. Estimates of the prevalence of childhood maladjustment in a community survey in Puerto Rico. Arch General Psychiatry. 45:1988;1120-1126.
30. Booth R.G., Baldessarini R.J., Marsh E., Owens C.E. Actions of (+/-)-7-hydroxy-N,N-dipropylaminotetralin (7-OH-DPAT) on dopamine synthesis in limbic and extrapyramidal regions of rat brain. Brain Res. 662:(1-2):1994;283-288.
31. Bradberry C.W., Lory J.D., Roth R.H. The anxiogenic beta-carboline FG 7142 selectively increases dopamine release in rat prefrontal cortex as measured by microdialysis. J Neurochem. 56:(3):1991;748-752.
32. Brandon C.L., Marinelli M., Baker L.K., White F.J. Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology. 25:(5):2001;651-661.
33. Brixey S.N., Gallagher B.J. 3rd, McFalls J.A. Jr., Parmelee L.F. Gestational and neonatal factors in the etiology of schizophrenia. J Clin Psychol. 49:(3):1993;447-456.
34. Broaddus W.C., Bennett J.P. Jr. Postnatal development of striatal dopamine function. I. An examination of D1 and D2 receptors, adenylate cyclase regulation and presynaptic dopamine markers. Brain Res Dev Brain Res. 52:(1-2):1990;265-271.
35. Campbell A., Baldessarini R. Effects of maturation and aging on behavioral response to haloperidol in the rat. Psychopharmacology. 73:1981;219-222.
36. Campbell A., Baldessarini R.J., Teicher M.H. Decreasing sensitivity to neuroleptic agents in developing rats: Evidence for a pharmacodynamic factor. Psychopharmacology. 94:1988;46-51.
37. Canuso C.M., Goldstein J.M., Green A.I. The evaluation of women with schizophrenia. Psychopharmacol Bull. 34:(3):1998;271-277.
38. Casey B.J., Giedd J.N., Thomas K.M. Structural and functional brain development and its relation to cognitive development. Biol Psychol. 54:(1-3):2000;241-257.
39. Castellanos F.X., Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci. 3:(8):2002;617-628.
40. Changeaux J.P., Danchin A. Selective stabilization of developing synapses as a mechanism for the specification of neuronal networks. Nature. 264:1976;705-712.
41. Corriveau R.A., Huh G.S., Shatz C.J. Regulation of class I MHC gene expression in the developing and mature CNS by neural activity. Neuron. 21:(3):1998;505-520.
42. Cousino K., Corwin E. Seeing the unexpected: how sex differences in stress responses may provide a new perspective on the manifestation of psychiatric disorders. Curr Psychiatr Rep. 4:(6):2002;441-448.
43. Coyle J.T., Campochiaro P. Ontogenesis of dopaminergic-cholinergic interactions in the rat striatum: a neurochemical study. J Neurochem. 27:(3):1976;673-678.
44. Creese I., Burt D.R., Snyder S.H. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science. 196:1977;326-328.
45. Cyranowski J.M., Frank E., Young E., Shear M.K. Adolescent onset of the gender difference in lifetime rates of major depression: a theoretical model. Arch Gen Psychiatry. 57:(1):2000;21-27.
46. Daval G., Verge D., Becerril A., Gozlan H., Spampinato U., Hamon M. Transient expression of 5-HT1A receptor binding sites in some areas of the rat CNS during postnatal development. Int J Dev Neurosci. 5:(3):1987;171-180.
47. De Bellis M.D., Keshavan M.S., Beers S.R., Hall J., Frustaci K., Masalehdan A., Noll J., Boring A.M. Sex differences in brain maturation during childhood and adolescence. Cereb Cortex. 11:(6):2001;552-557.
48. De Vries T.J., Mulder A.H., Schoffelmeer A.N. Differential ontogeny of functional dopamine and muscarinic receptors mediating presynaptic inhibition of neurotransmitter release and postsynaptic regulation of adenylate cyclase activity in rat striatum. Brain Res Dev Brain Res. 66:(1):1992;91-96.
49. Dettling A.C., Feldon J., Pryce C.R. Early deprivation and behavioral and physiological responses to social separation/novelty in the marmoset. Pharmacol Biochem Behav. 73:(1):2002;259-269.
50. Deutch A.Y., Lee M.C., Gillham M.H., Cameron D.A., Goldstein M., Iadarola M.J. Stress selectively increases fos protein in dopamine neurons innervating the prefrontal cortex. Cereb Cortex. 1:(4):1991;273-292.
51. Diefenbach T.J., Sloley B.D., Goldberg J.I. Neurite branch development of an identified serotonergic neuron from embryonic Helisoma: evidence for autoregulation by serotonin. Dev Biol. 167:(1):1995;282-293.
52. Dieudonne M., Pecquery R., Dausse J., Giudicelli Y. Regulation of white adipocyte guanin nucleotide binding proteins Gs alpha and Gi alpha 1-2 by testosterone in vivo: influence of regional fat distribution. Biochim Biophys Acta. 1176:1993;123-127.
53. Dinopoulos A., Dori I., Parnavelas J.G. The serotonin innervation of the basal forebrain shows a transient phase during development. Brain Res Dev Brain Res. 99:(1):1997;38-52.
54. Dorn L.D., Chrousos G.P. The neurobiology of stress: understanding regulation of affect during female biological transitions. Semin Reprod Endocrinol. 15:(1):1997;19-35.
55. Dow-Edwards D., Mayes L., Spear L., Hurd Y. Cocaine and development: clinical, behavioral, and neurobiological perspectives - a symposium report. Neurotoxicol Teratol. 21:(5):1999;481-490.
56. Dow-Edwards D.L. Preweaning cocaine administration alters the adult response to quipazine: comparison with fluoxetine. Neurotoxicol Teratol. 20:(2):1998;133-142.
57. Dow-Edwards D.L., Freed-Malen L.A., Gerkin L.M. Sexual dimorphism in the brain metabolic response to prenatal cocaine exposure. Brain Res Dev Brain Res. 129:(1):2001;73-79.
58. Duman R.S. Synaptic plasticity and mood disorders. Mol Psychiatry. 7:(1):2002;S29-S34.
59. Edwards H.E., MacLusky N.J., Burnham W.M. The effect of seizures and kindling on reproductive hormones in the rat. Neurosci Biobehav Rev. 24:(7):2000;753-762.
60. Engelbregt M.J., van Weissenbruch M.M., Popp-Snijders C., Lips P., Delemarre-van de Waal H.A. Body mass index, body composition, and leptin at onset of puberty in male and female rats after intrauterine growth retardation and after early postnatal food restriction. Pediatr Res. 50:(4):2001;474-478.
61. Fagiolini M., Hensch T.K. Inhibitory threshold for critical-period activation in primary visual cortex. Nature. 404:(6774):2000;183-186.
62. Faraone S.V., Doyle A.E. The nature and heritability of attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am. 10:(2):2001;299-316. viii-ix.
63. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res. 17:1982-3;319-334.
64. Fishbein D. The importance of neurobiological research to the prevention of psychopathology. Prev Sci. 1:(2):2000;89-106.
65. Fox K., Daw N., Sato H., Czepita D. Dark-rearing delays the loss of NMDA-receptor function in kitten visual cortex. Nature. 350:(6316):1991;342-344.
66. Fox K., Zahs K. Critical period control in sensory cortex. Curr Opin Neurobiol. 4:(1):1994;112-119.
67. Fried P.A. Marihuana use by pregnant women and effects on offspring: an update. Neurobehav Toxicol Teratol. 4:(4):1982;451-454.
68. Gatley S.J., Meehan S.M., Chen R., Pan D.F., Schechter M.D., Dewey S.L. Place preference and microdialysis studies with two derivatives of methylphenidate. Life Sci. 58:(24):1996;L345-L352.
69. Gazzara R.A., Andersen S.L. The ontogeny of apomorphine-induced alterations of neostriatal dopamine release: effects on potassium-evoked release. Neurochem Res. 19:(3):1994;339-345.
70. Gelbard H.A., Teicher M.H., Baldessarini R.J., Gallitano A., Marsh E.R., Zorc J., Faedda G. Dopamine D1 receptor development depends on endogenous dopamine. Brain Res Dev Brain Res. 56:(1):1990;137-140.
71. Gelbard H.A., Teicher M.H., Faedda J.G., Baldessarini R.J. Postnatal development of dopamine D1 and D2 receptor sites in rat striatum. Brain Res. 49:1989;123-130.
72. Giedd J.N., Blumenthal J., Jeffries N.O., Castellanos F.X., Liu H., Zijdenbos A., Paus T., Evans A.C., Rapoport J.L. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci. 2:(10):1999;861-863.
73. Giedd J.N., Rumsey J.M., Castellanos F.X., Rajapakse J.C., Kaysen D., Vaituzis A.C., Vauss Y.C., Hamburger S.D., Rapoport J.L. A quantitative MRI study of the corpus callosum in children and adolescents. Brain Res Dev Brain Res. 91:(2):1996;274-280.
74. Giedd J.N., Snell J.W., Lange N., Rajapakse J.C., Casey B.J., Kozuch P.L., Vaituzis A.C., Vauss Y.C., Hamburger S.D., Kaysen D., Rapoport J.L. Quantitative magnetic resonance imaging of human brain development: ages 4-18. Cereb Cortex. 6:(4):1996;551-560.
75. Giedd J.N., Vaituzis A.C., Hamburger S.D., Lange N., Rajapakse J.C., Kaysen D., Vauss Y.C., Rapoport J.L. Quantitative MRI of the temporal lobe, amygdala, and hippocampus in normal human development: ages 4-18 years. J Comp Neurol. 366:(2):1996;223-230.
76. Godement P., Salaun J., Metin C. Fate of uncrossed retinal projections following early or late prenatal monocular enucleation in the mouse. J Comp Neurol. 255:(1):1987;97-109.
77. Goldman-Rakic P.S., Brown R.M. Postnatal development of monoamine content and synthesis in the cerebral cortex of rhesus monkeys. Brain Res. 256:(3):1982;339-349.
78. Goldstein J., Seidman L., Goodman J., Koren D., Lee H., Weintraub S., Tsuang M. Are there sex differences in neuropsychological functions among patients with schizophrenia? Am J Psychiatry. 155:1998;1358-1364.
79. Goldstein J.M., Seidman L.J., O'Brien L.M., Horton N.J., Kennedy D.N., Makris N., Caviness V.S. Jr, Faraone S.V., Tsuang M.T. Impact of normal sexual dimorphisms on sex differences in structural brain abnormalities in schizophrenia assessed by magnetic resonance imaging. Arch Gen Psychiatry. 59:(2):2002;154-164.
80. Gooney M., Shaw K., Kelly A., O'Mara S.M., Lynch M.A. Long-term potentiation and spatial learning are associated with increased phosphorylation of TrkB and extracellular signal-regulated kinase (ERK) in the dentate gyrus: evidence for a role for brain-derived neurotrophic factor. Behav Neurosci. 116:(3):2002;455-463.
81. Grace A.A., Bunney B.S., Moore H., Todd C.L. Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs. Trends Neurosci. 20:(1):1997;31-37.
82. Black J.E., Greenough W.T. Learning and memory. 2nd ed Learning and memory. 1991;Academic Press, New York.
83. Grigoriadis S., Seeman M.V. The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women. Can J Psychiatry. 47:(5):2002;437-442.
84. Guillin O., Diaz J., Carroll P., Griffon N., Schwartz J.C., Sokoloff P. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature. 411:(6833):2001;86-89.
85. Guivarc'h D., Vernier P., Vincent J. Sex steroid hormones change the differential distribution of the isoforms of the D2 dopamine receptor messenger RNA in the rat brain. Neuroscience. 69:1995;159-166.
86. Hafner H., Behrens S., De Vry J., Gattaz W.F. Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic neurotransmission. Evidence from an epidemiological study and from animal experiments. Eur Arch Psychiatry Clin Neurosci. 241:(1):1991;65-68.
87. Halbreich U., Kahn L.S. Role of estrogen in the aetiology and treatment of mood disorders. CNS Drugs. 15:(10):2001;797-817.
88. Hall F.S. Social deprivation of neonatal, adolescent, and adult rats has distinct neurochemical and behavioral consequences. Crit Rev Neurobiol. 12:(1-2):1998;129-162.
89. Hanover J.L., Huang Z.J., Tonegawa S., Stryker M.P. Brain-derived neurotrophic factor overexpression induces precocious critical period in mouse visual cortex. J Neurosci. 19:(22):1999;RC40.
90. Hattori T., Takada M., Moriizumi T., Campbell K.J. Direct striatothalamic projections in the neonatal rat. Brain Res Dev Brain Res. 54:(1):1990;137-141.
91. Hess E.H. The natural history of imprinting. Ann NY Acad Sci. 193:1972;124-136.
92. Hiort O. Androgens and puberty. Best Pract Res Clin Endocrinol Metab. 16:(1):2002;31-41.
93. Hoffman R.E., Dobscha S.K. Cortical pruning and the development of schizophrenia: a computer model. Schizophr Bull. 15:1989;477.
94. Holden C. Mental health. Global survey examines impact of depression. Science. 288:(5463):2000;39-40.
95. Howard S.G., Fisher R., Landry C.F. Alterations in the spontaneous release of dopamine and the density of the DA D2 receptor mRNA after chronic postnatal exposure to cocaine. Brain Res Bull. 43:(1):1997;101-106.
96. Hubel D.H., Wiesel T.N. The period of susceptibility to the physiological effects of unilateral eye closure in kittens. J Physiol. 206:(2):1970;419-436.
97. Hubel D.H., Wiesel T.N. Early exploration of the visual cortex. Neuron. 20:(3):1998;401-412.
98. Huttenlocher P.R. Synaptic density in human frontal cortex - developmental changes and effects of aging. Brain Res. 163:(2):1979;195-205.
99. Huttenlocher P.R., de Courten C. The development of synapses in striate cortex of man. Hum Neurobiol. 6:(1):1987;1-9.
100. Innocenti G.M. Growth and reshaping of axons in the establishment of visual callosal connections. Science. 212:1981;824-827.
101. Insel T.R. The development of brain and behavior. Bloom F.E., Kupfer D.J. Psychopharmacology: the fourth generation of progress. 1995;683-694 Raven Press, New York.
102. Jacobson M. Genesis of neuronal specificity. Rockstein M. Development and aging in the nervous system. 1973;103 Academic Press, New York.
103. Jacobson M. Developmental neurobiology. 1991;Plenum Press, New York.
104. Jones J.I., Gockerman A., Busby W.H. Jr., Wright G., Clemmons D.R. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA. 90:(22):1993;10553-10557.
105. 125I]HEAT in normal rats and rats treated with alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase. Neuroscience. 15:(4):1985;1195-1202.
106. Jung A.B., Bennett J.P. Jr. Development of striatal dopaminergic function. III: pre- and postnatal development of striatal and cortical mRNAs for the neurotrophin receptors trkBTK+ and trkC and their regulation by synaptic dopamine. Brain Res Dev Brain Res. 94:(2):1996;133-143.
107. Kalsbeek A., Voorn P., Buijs R.M., Pool C.W., Uylings H.B. Development of the dopaminergic innervation in the prefrontal cortex of the rat. J Comp Neurol. 269:(1):1988;58-72.
108. Kato C., Petronis A., Okazaki Y., Tochigi M., Umekage T., Sasaki T. Molecular genetic studies of schizophrenia: challenges and insights. Neurosci Res. 43:(4):2002;295-304.
109. Kaufman J., Charney D. Effects of early stress on brain structure and function: implications for understanding the relationship between child maltreatment and depression. Dev Psychopathol. 13:(3):2001;451-471.
110. Keller H.H., Bartholini G., Pletscher A. Spontaneous and drug-induced changes of cerebral dopamine turnover during postnatal development of rats. Brain Res. 64:1973;371-378.
111. Keshavan M.S., Diwadkar V.A., DeBellis M., Dick E., Kotwal R., Rosenberg D.R., Sweeney J.A., Minshew N., Pettegrew J.W. Development of the corpus callosum in childhood, adolescence and early adulthood. Life Sci. 70:(16):2002;1909-1922.
112. Keshaven M., Anderson S., Pettegrew J.W. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. Journal of Psychiatric Research. 28:1994;239.
113. Keverne E.B. Genomic imprinting in the brain. Curr Opin Neurobiol. 7:(4):1997;463-468.
114. Keverne E.B., Fundele R., Narasimha M., Barton S.C., Surani M.A. Genomic imprinting and the differential roles of parental genomes in brain development. Brain Res Dev Brain Res. 92:(1):1996;91-100.
115. Kiss J.Z., Troncoso E., Djebbara Z., Vutskits L., Muller D. The role of neural cell adhesion molecules in plasticity and repair. Brain Res Brain Res Rev. 36:(2-3):2001;175-184.
116. Knoll B., Drescher U. Ephrin - As as receptors in topographic projections. Trends Neurosci. 25:(3):2002;145-149.
117. Koob G.F. Neurobiology of addiction. Toward the development of new therapies. Ann NY Acad Sci. 909:2000;170-185.
118. Kosofsky B.E., Hyman S.E. No time for complacency: the fetal brain on drugs. J Comp Neurol. 435:(3):2001;259-262.
119. Kostrzewa R.M., Saleh M.I. Impaired ontogeny of striatal dopamine D1 and D2 binding sites after postnatal treatment of rats with SCH-23390 and spiroperidol. Brain Res Dev Brain Res. 45:(1):1989;95-101.
120. Kuczenski R., Segal D.S. Dynamic changes in sensitivity occur during the acute response to cocaine and methylphenidate. Psychopharmacol (Berl). 147:(1):1999;96-103.
121. Kuhn C.M., Pauk J., Schanberg S.M. Endocrine responses to mother-infant separation in developing rats. Dev Psychobiol. 23:(5):1990;395-410.
122. Kukstas L., Domec C., Bascles L., Bonnet J., Verrier D., Israel J., Vincent J. Different expression of the two dopaminergic D2 receptors, D2415 and D2455, in two tpes of lactotroph each characterized by their response to dopamine, and modification of expression by sex steroids. Endocrinology. 129:1991;1101-1103.
123. Kuppermann B.D., Kasamatsu T. Enhanced binocular interaction in the visual cortex of normal kittens subjected to intracortical norepinephrine perfusion. Brain Res. 302:(1):1984;91-99.
124. Landmesser L.T. The generation of neuromuscular specificity. Ann Rev Neurosci. 3:1980;279-302.
125. Lankford K.L., DeMello F.G., Klein W.L. D1-type dopamine receptors inhibit growth cone motility in cultured retina neurons: evidence that neurotransmitters act as morphogenic growth regulators in the developing central nervous system. Proc Natl Acad Sci USA. 85:(12):1988;4567-4571.
126. Lauder J.M., Krebs H. Serotonin as a differentiation signal in early neurogenesis. Dev Neurosci. 1:(1):1978;15-30.
127. Laviola G., Dell'Omo G., Chiarotti F., Bignami G. d-amphetamine conditioned place preference in developing mice: relations with changes in activity and stereotypies. Behav Neurosci. 108:(3):1994;514-524.
128. Laviola G., Wood R.D., Kuhn C., Francis R., Spear L.P. Cocaine sensitization in periadolescent and adult rats. J Pharmacol Exp Ther. 275:(1):1995;345-357.
129. Leckman J.F., Pauls D.L., Cohen D.J. Tic disorders. Bloom F.E., Kupfer D.J. Psychopharmacology: the fourth generation of progress. 1995;1665-1674 Raven Press, New York.
130. Leon M. The neurobiology of filial learning. Annu Rev Psychol. 43:1992;377-398.
131. Lerner P., Nose P., Gordon E.K., Lovenberg W. Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover. Science. 197:(4299):1977;181-183.
132. Levine S.P., Towell B.L., Suarez A.M., Knieriem L.K., Harris M.M., George J.N. Platelet activation and secretion associated with emotional stress. Circulation. 71:(6):1985;1129-1134.
133. Levitt P., Harvey J.A., Friedman E., Simansky K., Murphy E.H. New evidence for neurotransmitter influences on brain development. Trends Neurosci. 20:(6):1997;269-274.
134. Lewine R.J. Gender and schizophrenia. Tsuang M.T., Simpson J.C. Handbook of Schizophrenia: nosology, epidemiology and genetics. 1988;379 Elsevier, Amsterdam.
135. Lewis D.A. Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology. 16:(6):1997;385-398.
136. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet. 3:(9):2002;662-673.
137. Lidow M.S. Cocaine abuse and corticogenesis. Trends Neurosci. 21:(1):1998;19-20.
138. Lidow M.S., Goldman-Rakic P.S., Rakic P. Synchronized overproduction of neurotransmitter receptors in diverse regions of the primate cerebral cortex. Proc Natl Acad Sci. 88:1991;10218.
139. Lightman S.L., Insel T.R., Ingram C.D. New genomic avenues in behavioural neuroendocrinology. Eur J Neurosci. 16:(3):2002;369-372.
140. Lightman S.L., Windle R.J., Julian M.D., Harbuz M.S., Shanks N., Wood S.A., Kershaw Y.M., Ingram C.D. Significance of pulsatility in the HPA axis. Novartis Found Symp. 227:2000;244-257.
141. Lillrank S.M., Lipska B.K., Weinberger D.R. Neurodevelopmental animal models of schizophrenia. Clin Neurosci. 3:(2):1995;98-104.
142. Lipska B.K., Jaskiw G.E., Weinberger D.R. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology. 9:(1):1993;67-75.
143. Lipska B.K., Swerdlow N.R., Geyer M.A., Jaskiw G.E., Braff D.L., Weinberger D.R. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacol (Berl). 122:(1):1995;35-43.
144. Lipska B.K., Weinberger D.R. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat. Brain Res Dev Brain Res. 75:(2):1993;213-222.
145. Livingstone J.D., Lerant A., Freeman M.E. Ovarian steroids modulate responsiveness to dopamine and expression of G-proteins in lactotropes. Neuroendocrinology. 68:(3):1998;172-179.
146. Lyss P.J., Andersen S.L., LeBlanc C.J., Teicher M.H. Degree of neuronal activation following FG-7142 changes across regions during development. Brain Res Dev Brain Res. 116:(2):1999;201-203.
147. Mailleux P., Pelaprat D., Vanderhaeghen J.J. Transient neurotensin high-affinity binding sites in the human inferior olive during development. Brain Res. 508:(2):1990;345-348.
148. Marenco S., Weinberger D.R. The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev Psychopathol. 12:(3):2000;501-527.
149. Mattson M.P. Neurotransmitters in the regulation of neuronal cytoarchitecture. Brain Res. 472:(2):1988;179-212.
150. Mazer C., Muneyyirci J., Taheny K., Raio N., Borella A., Whitaker-Azmitia P. Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits. Brain Res. 760:(1-2):1997;68-73.
151. McEwen B.S. Gonadal steroid influences on brain development and sexual differentiation. Int Rev Physiol. 27:1983;99-145.
152. McEwen B.S. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci. 12:(4):1991;141-147.
153. McGivern R.F., Handa R.J. Prenatal exposure to drugs of abuse: methodological considerations and effects on sexual differentiation. NIDA Res Monogr. 164:1996;78-124.
154. McGuffin P., Riley B., Plomin R. Genomics and behavior. Toward behavioral genomics. Science. 291:(5507):2001;1232-1249.
155. Mermelstein P.G., Becker J.B., Surmeier D.J. Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J Neurosci. 16:(2):1996;595-604.
156. Mirnics K., Middleton F.A., Lewis D.A., Levitt P. The human genome: gene expression profiling and schizophrenia. Am J Psychiatry. 158:(9):2001;1384.
157. Morency M., Beninger R. Dopaminergic substrates of cocaine-induced place conditioning. Brain Res. 199:1987;33-41.
158. Mucha R., Kooy D.V.D., O'Shaughness M., Bucenieks P. Drug reinforcement studies by the use of place conditioning in rat. Brain Res. 243:1982;91-105.
159. Murrin L.C., Zeng W. Postnatal ontogeny of dopamine D2 receptors in rat striatum. Biochem Pharmacol. 35:(7):1986;1159-1162.
160. Nestler E.J., Landsman D. Learning about addiction from the genome. Nature. 409:(6822):2001;834-835.
161. Noisin E.L., Thomas W.E. Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex [published erratum appears in Brain Res 1989 May, 47(1) (1) 160]. Brain Res. 469:(1-2):1988;241-252.
162. Novik K.L., Nimmrich I., Genc B., Maier S., Piepenbrock C., Olek A., Beck S. Epigenomics: genome-wide study of methylation phenomena. Curr Issues Mol Biol. 4:(4):2002;111-128.
163. Pardo J.V., Creese I., Burt D.R., Snyder S.H. Ontogenesis of dopamine receptor binding in the corpus striatum of the rat. Brain Res. 125:(2):1977;376-382.
164. Peterson B.S., Leckman J.F., Scahill L., Naftolin F., Keefe D., Charest N.J., Cohen D.J. Steroid hormones and CNS sexual dimorphisms modulate symptom expression in Tourette's syndrome. Psychoneuroendocrinology. 17:(6):1992;553-563.
165. Petronis A. The genes for major psychosis: aberrant sequence or regulation? Neuropsychopharmacology. 23:(1):2000;1-12.
166. Pihoker C., Owens M.J., Kuhn C.M., Schanberg S.M., Nemeroff C.B. Maternal separation in neonatal rats elicits activation of the hypothalamic-pituitary-adrenocortical axis: a putative role for corticotropin-releasing factor. Psychoneuroendocrinology. 18:(7):1993;485-493.
167. Pitts D.K., Freeman A.S., Chiodo L.A. Dopamine neuron ontogeny: electrophysiological studies. Synapse. 6:(4):1990;309-320.
168. Plotsky P.M., Thrivikraman K.V., Meaney M.J. Central and feedback regulation of hypothalamic corticotropin-releasing factor secretion. Ciba Found Symp. 172:1993;59-75.
169. Preece M.A. Puberty in children with intrauterine growth retardation Horm Res. 48:(1):1997;30-32.
170. Pujol J., Vendrell P., Junque C., Marti-Vilalta J.L., Capdevila A. When does human brain development end? Evidence of corpus callosum growth up to adulthood. Ann Neurol. 34:(1):1993;71-75.
171. Purves D. Body and brain: a trophic theory of neural connections. 1988;Harvard University Press, Cambridge, MA.
172. Purves D., Lichtman J.W. Elimination of synapses in the developing nervous system. Science. 210:(4466):1980;153-157.
173. Rakic P. Development of visual centers in the primate brain depends on binocular competition before birth. Science. 214:(4523):1981;928-931.
174. Rakic P. Development of the primate cerebral cortex. Lewis M. Child and adolescent psychiatry. 1991;Williams and Wilkins, Baltimore.
175. Rakic P., Bourgeois J.P., Eckenhoff M.F., Zecevic N., Goldman-Rakic P.S. Concurrent overproduction of synapses in diverse regions of the primate cerebral cortex. Science. 232:(4747):1986;232-235.
176. Rao P.A., Molinoff P.B., Joyce J.N. Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Brain Res Dev Brain Res. 60:(2):1991;161-177.
177. Rapoport J.L., Castellanos F.X., Gogate N., Janson K., Kohler S., Nelson P. Imaging normal and abnormal brain development: new perspectives for child psychiatry. Aust NZ J Psychiatry. 35:(3):2001;272-281.
178. Reik W., Dean W., Walter J. Epigenetic reprogramming in mammalian development. Science. 293:(5532):2001;1089-1093.
179. Rosenberg D.R., Lewis D.A. Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: a tyrosine hydroxylase immunohistochemical analysis. J Comp Neurol. 358:(3):1995;383-400.
180. Rosengarten H., Friedhoff A.J. Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats. Science. 203:(4385):1979;1133-1135.
181. Roth R.H., Bacopoulos N.G., Bustos G., Redmond D.E. Jr. Antipsychotic drugs: differential effects on dopamine neurons in basal ganglia and mesocortex following chronic administration in human and nonhuman primates. Adv Biochem Psychopharmacol. 24:1980;513-520.
182. Saenger P., Dimartino-Nardi J. Premature adrenarche. J Endocrinol Invest. 24:(9):2001;724-733.
183. Summary of findings from the 1998 national household survey on drug abuse. 1999;US Department of Health and Human Services, Rockville, MD. pp. 128.
184. Sanchez M.M., Ladd C.O., Plotsky P.M. Early adverse experience as a developmental risk factor for later psychopathology: evidence from rodent and primate models. Dev Psychopathol. 13:(3):2001;419-449.
185. Sandyk R. Biological determinants and risk factors for tardive
186. Sapolsky R.M., Meaney M.J. Maturation of the adrenocortical stress response: neuroendocrine control mechanisms and the stress hyporesponsive period. Brain Res. 396:(1):1986;64-76.
187. Scalzo F.M., Spear L.P. Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult rats. Psychopharmacology. 85:(3):1985;271-276.
188. Seeman M. The role of sex hormones in psychopathology: focus on schizophrenia. Primary Care. 29:(1):2002;171-182.
189. Seeman M.V., Lang M. The role of estrogens in schizophrenia gender differences. Schizophr Bull. 16:(2):1990;185-194.
190. Seeman P., Bzowej N.H., Guan H.C., Bergeron C., Becker L.E., Reynolds G.P., Bird E.D., Riederer P., Jellinger K., Watanabe S., et al. Human brain dopamine receptors in children and aging adults. Synapse. 1:(5):1987;399-404.
191. Shemer A.V., Azmitia E.C., Whitaker-Azmitia P.M. Dose-related effects of prenatal 5-methoxytryptamine (5-MT) on development of serotonin terminal density and behavior. Brain Res Dev Brain Res. 59:(1):1991;59-63.
192. Sidman R.L., Rakic P. Neuronal migration, with special reference to developing human brain: a review. Brain Res. 62:(1):1973;1-35.
193. Slob A.K., Huizer T., Van der Werff ten Bosch J.J. Ontogeny of sex differences in open-field ambulation in the rat. Physiol Behav. 37:(2):1986;313-315.
194. Snyder-Keller A., Keller R.W. Jr. Stimulant-mediated c-fos induction in striatum as a function of age, sex, and prenatal cocaine exposure. Brain Res. 794:(1):1998;88-95.
195. Spear L. The adolescent brain and age-related behavioral manifestations. Neurosci Bio-behav Rev. 24:2000;417-463.
196. Spear L.P., Brake S.C. Periadolescence: age-dependent behavior and psychopharmacological responsivity in rats. Dev Psychobiol. 16:(2):1983;83-109.
197. Spear L.P., Shalaby I.A., Brick J. Chronic administration of haloperidol during development: behavioral and psychopharmacological effects. Psychopharmacology. 70:(1):1980;47-58.
198. Sretavan D.W., Shatz C.J. Prenatal development of cat retinogeniculate axon arbors in the absence of binocular interactions. J Neurosci. 6:(4):1986;990-1003.
199. Stevens R., Goldstein R. Effects of neonatal testosterone and estrogen on open-field behaviour in rats. Physiol Behav. 26:(3):1981;551-553.
200. Stewart J., Cygan D. Ovarian hormones act early in development to feminize adult open-field behavior in the rat. Horm Behav. 14:1980;20-32.
201. Stewart J., Skvarenina A., Pottier J. Effects of neonatal androgens on open-field behavior and maze learning in the prepubescent and adult rat. Physiol Behav. 14:(3):1975;291-295.
202. Swarzenski B.C., Tang L., Oh Y.J., O'Malley K.L., Todd R.D. Morphogenic potentials of D2, D3, and D4 dopamine receptors revealed in transfected neuronal cell lines. Proc Natl Acad Sci USA. 91:(2):1994;649-653.
203. Tang K., Low M.J., Grandy D.K., Lovinger D.M. Dopamine-dependent synaptic plasticity in striatum during in vivo development. Proc Natl Acad Sci USA. 98:(3):2001;1255-1260.
204. Tarter R., Vanyukov M., Giancola P., Dawes M., Blackson T., Mezzich A., Clark D.B. Etiology of early age onset substance use disorder: a maturational perspective. Dev Psychopathol. 11:(4):1999;657-683.
205. Tashima L., Nakata M., Anno K., Sugino N., Kato H. Prenatal influence of ischemia-hypoxia-induced intrauterine growth retardation on brain development and behavioral activity in rats. Biol Neonate. 80:(1):2001;81-87.
206. Tatum A., Seevers M. Experimental cocaine addiction. J Pharmacol Exp Therapeut. 36:1929;401-410.
207. Teicher M., Dumont N., Andersen S. The developing prefrontal cortex: Is there a transient interneuron that stimulates catecholamine terminals? Synapse. 28:1998;89-91.
208. Teicher M.H., Andersen S.L., Glod C.A., Navalta C.P., Gelbard H.A. The american psychiatric press textbook of neuropsychiatry. The american psychiatric press textbook of neuropsychiatry. 1997;American Psychiatric Press, Washington, DC.
209. Teicher M.H., Andersen S.L., Hostetter J.C. Jr. Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens. Brain Res Dev Brain Res. 89:(2):1995;167-172.
210. Teicher M.H., Barber N.I., Gelbard H.A., Gallitano A.L., Campbell A., Marsh E., Baldessarini R.J. Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol. Neuropsychopharmacology. 9:(2):1993;147-156.
211. Teicher M.H., Gallitano A.L., Gelbard H.A., Evans H.K., Marsh E.R., Booth R.G., Baldessarini R.J. Dopamine D1 autoreceptor function: possible expression in developing rat prefrontal cortex and striatum. Brain Res Dev Brain Res. 63:(1-2):1991;229-235.
212. Tepper J.M., Trent F., Nakamura S. Postnatal development of the electrical activity of rat nigrostriatal dopaminergic neurons. Brain Res Dev Brain Res. 54:(1):1990;21-33.
213. Timmusk T., Belluardo N., Persson H., Metsis M. Developmental regulation of brain-derived neurotrophic factor messenger RNAs transcribed from different promoters in the rat brain. Neuroscience. 60:(2):1994;287-291.
214. Tischkau S.A., Ramirez V.D. A specific membrane binding protein for progesterone in rat brain: sex differences and induction by estrogen. Proc Natl Acad Sci USA. 90:(4):1993;1285-1289.
215. Tobet S.A. Genes controlling hypothalamic development and sexual differentiation. Eur J Neurosci. 16:(3):2002;373-376.
216. Todd R.D. Neural development is regulated by classical neurotransmitters: dopamine D2 receptor stimulation enhances neurite outgrowth. Biol Psychiatry. 31:(8):1992;794-807.
217. Tsuang M. Schizophrenia: genes and environment. Biol Psychiatry. 47:(3):2000;210-220.
218. Upton A.L., Salichon N., Lebrand C., Ravary A., Blakely R., Seif I., Gaspar P. Excess of serotonin (5-HT) alters the segregation of ispilateral and contralateral retinal projections in monoamine oxidase A knock-out mice: possible role of 5-HT uptake in retinal ganglion cells during development. J Neurosci. 19:(16):1999;7007-7024.
219. Velazquez-Moctezuma J., Diaz Ruiz O. Neonatal treatment with clomipramine increased immobility in the forced swim test: an attribute of animal models of depression. Pharmacol Biochem Behav. 42:(4):1992;737-739.
220. Vermetten E., Bremner J.D. Circuits and systems in stress. I. Preclinical studies. Depress Anxiety. 15:(3):2002;126-147.
221. Vizuete M.L., Venero J.L., Traiffort E., Vargas C., Machado A., Cano J. Expression of 5-HT7 receptor mRNA in rat brain during postnatal development. Neurosci Lett. 227:(1):1997;53-56.
222. Vogel G., Neill D., Hagler M., Kors D. A new animal model of endogenous depression: a summary of present findings. Neurosci Biobehav Rev. 14:(1):1990;85-91.
223. Vogel G., Neill D., Kors D., Hagler M. REM sleep abnormalities in a new animal model of endogenous depression. Neurosci Biobehav Rev. 14:(1):1990;77-83.
224. Walker E.F. Developmentally moderated expressions of the neuropathology underlying schizophrenia. Schizophr Bull. 20:(3):1994;453-480.
225. Wang G.H. Relation between spontaneous activity and estrous cycle in the white rat. Comp Psychol Monogr. 2:1923;1-27.
226. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 44:(7):1987;660-669.
227. Whitaker-Azmitia P.M. Role of serotonin and other neurotransmitter receptors in brain development: basis for developmental pharmacology. Pharmacol Rev. 43:(4):1991;553-561.
228. Whitaker-Azmitia P.M., Azmitia E.C. Autoregulation of fetal serotonergic neuronal development: role of high affinity serotonin receptors. Neurosci Lett. 67:(3):1986;307-312.
229. Williams D.I., Russell P.A. Open-field behaviour in rats: effects of handling sex and repeated testing. Br J Psychol. 63:(4):1972;593-596.
230. Witelson S.F. Hand and sex differences in the isthmus and genu of the human corpus callosum. A postmortem morphological study. Brain. 112:1989;799-835.
231. Xiao L., Becker J.B. Effects of estrogen agonists on amphetamine-stimulated striatal dopamine release. Synapse. 29:(4):1998;379-391.
232. Yokosuka M., Okamura H., Hayashi S. Transient expression of estrogen receptor-immunoreactivity (ER-IR) in the layer V of the developing rat cerebral cortex. Brain Res Dev Brain Res. 84:(1):1995;99-108.
233. Zheng D., Purves D. Effects of increased neural activity on brain growth. Proc Natl Acad Sci USA. 92:(6):1995;1802-1806.